New Acne Study Shows Combined Therapy Beats Standard Care

A recent trial looked at sixty people with moderate to severe cystic acne. They were split into two groups at random. One group got the usual pill isotretinoin plus red and blue light therapy. The other group received a blend of two herbal formulas, a special needle technique, and the same light treatment. Both groups also used a topical retinoid and followed identical skin care advice.

Researchers checked the skin at the start, after three treatment cycles, and after six cycles. Both approaches lowered the overall acne score, cut the number of lesions, and improved quality of life scores. However, the herbal‑plus‑needle combo showed a bigger drop after three and six cycles. About forty‑seven percent of the standard group reached a cure or strong improvement, while seventy‑seven percent did so in the combined group.

Side effects were similar between the two arms, suggesting the extra therapies did not add safety concerns. In a follow‑up that only included people who had already responded well, the combined group had lower scar ratings, better scores on a scar scale, and less redness on imaging during the first three months. This extra data is considered exploratory because it did not keep the original random comparison.

The short‑term randomized results hint that the integrated regimen deserves more study. The responder‑only findings need confirmation in a trial that follows everyone from the start. Until then, clinicians should weigh the potential benefits against the added complexity of the herbal and needle components.